Carmen Criscitiello - Concepedia

Author

Carmen Criscitiello

Also Known As

Andrea Vingiani, C Criscitiello, C. Criscitiello, Carmen Ballesteroes-Merino, Carmen Ballesteros-Merino, Carmen Criscitiello, Nicolò, Eleonora, Tolaney, Sara M., Trapani, Dario

358

Publications

16.7K

Citations

H-Index

Concepts

All Affiliations

European Institute of Oncology University of Milan Istituti di Ricovero e Cura a Carattere Scientifico Institut Jules Bordet Dana-Farber Cancer Institute

About

Carmen Criscitiello is an author at European Institute of Oncology specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	29	6K
2	Engineering	3	3	92
3	Health Sciences	3	3	46
4	Public Health	2	2	314
5	Nursing	1	1	25

Carmen Criscitiello

Publications

8.3K

Citations

H-Index

Page 1

	Year	Citations
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 Roberto Salgado, Carsten Denkert, Sandra Demaria, Annals of Oncology Lymphoid NeoplasiaBreast OncologyCancer ImmunosurveillanceMedicineImmunology	2014	3K
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines Giuseppe Curigliano, Daniela Cardinale, Thomas Suter, Annals of Oncology Radiation MedicineOncologyRadiation TherapyCardiovascular DiseasePharmacotherapy	2012	845
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study Maria Vittoria Dieci, Carmen Criscitiello, Aïcha Goubar, Annals of Oncology Residual DiseaseBreast OncologyMedicinePrognostic ValueImmunology	2014	461
Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling Hatem A. Azim, Stefan Michiels, Philippe L. Bédard, Clinical Cancer Research	2012	418
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus Giuseppe Curigliano, Susana Banerjee, Andrés Cervantes, Annals of Oncology Health PolicyMedicineGlobal HealthCancer ManagementGlobal Health Crisis	2020	303
Global cancer control: responding to the growing burden, rising costs and inequalities in access Gerald W. Prager, Sofía Braga, Branislav Bystrický, ESMO Open	2018	298
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy J H Park, Sarah Flora Jonas, Guillaume Bataillon, Annals of Oncology Breast OncologyCancer ImmunosurveillanceMedicinePrognostic ValueImmunology	2019	259
Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled Analysis Michail Ignatiadis, Sandeep K. Singhal, Christine Desmedt, Journal of Clinical Oncology	2012	215
HER2-Positive Circulating Tumor Cells in Breast Cancer Michail Ignatiadis, Françoise Rothé, Carole Chaboteaux, PLoS ONE	2011	205
Evolution of low HER2 expression between early and advanced-stage breast cancer Paolo Tarantino, Sara Gandini, Eleonora Nicolò, European Journal of Cancer Radiation OncologyBreast OncologyMedicineLow Her2 ExpressionBreast Cancer	2022	195

Page 1